Top Markets
#1 Pleasing Gold Pleasing Gold +1,049.05%
#2 PulseChain PulseChain +56.32%
#3 BOOK OF MEME BOOK OF MEME +39.77%
#4 DogBull DogBull +36.74%
#5 Ontology Gas Ontology Gas +25.60%
#6 Neiro Neiro +22.37%
#7 Unit Pump Unit Pump +21.94%
#8 Pump.fun Pump.fun +18.98%
#9 rsERG rsERG +17.44%
#10 Ergo Ergo +16.78%
Coin of the day
Pleasing Gold Pleasing Gold
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ProMIS Neurosciences, Inc. ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc.

PMN
Rang in Aktien #26784
Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing... Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing precise medical solutions for severe neurodegenerative disorders, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company employs a unique discovery platform, which incorporates proprietary algorithms like ProMIS and Collective Coordinates, to identify novel, disease-specific targets, known as epitopes, located on the surface of misfolded proteins. The firm's primary product candidates include PMN310, a monoclonal antibody designed to combat toxic oligomers associated with Alzheimer's disease. Another candidate, PMN267, aims to target proteins such as superoxide dismutase 1 and TAR-DNA binding protein 43 relevant to ALS, as well as alpha-synuclein implicated in Parkinson's disease and Lewy body dementia. Additionally, PMN442 is a monoclonal antibody engineered to address toxic alpha-synuclein oligomers and seeding fibrils linked to MSA. Originally established in 2004, the company was known as Amorfix Life Sciences Ltd. before officially adopting the name ProMIS Neurosciences, Inc. in July 2015.
Aktienkurs
$4.40
Zuletzt synchronisiert: 2023-07-21
Marktkapitalisierung
$37.78M
Veränderung (1 Tag)
-7.03%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel ProMIS Neurosciences, Inc. (PMN)

Kategorie

Healthcare
Dividendenhistorie für ProMIS Neurosciences, Inc. (PMN)
ProMIS Neurosciences, Inc. (Aktienkürzel: PMN) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für ProMIS Neurosciences, Inc. (PMN) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH